D-0474-2023 Class III Terminated
FDA drug recall D-0474-2023 was initiated by SUN PHARMACEUTICAL INDUSTRIES INC on Mar 9, 2023 and is designated Class III. Reason for recall: Failed Content Uniformity Specifications The recall status is terminated (terminated Oct 18, 2023). Affected quantity: 1,920 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Mar 29, 2023
- Initiation Date
- Mar 9, 2023
- Termination Date
- Oct 18, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1,920 bottles
Product description
Dofetilide Capsules, 500 mcg (0.5 mg), 60-count bottle, Rx only, Manufactured by: Sun Pharmaceutical Industries Limited, Survey No. 259/15, Dadra-396 191, (U.T. of D & NH), India, NDC 47335-0063-86
Reason for recall
Failed Content Uniformity Specifications
Distribution pattern
USA nationwide.
Code information
Lot # DND1541A, Exp 08/2024
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0474-2023
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026